THZ1 reveals CDK7-dependent transcriptional addictions in pancreatic cancer
- 28 January 2019
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 38 (20) , 3932-3945
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy with high mortality. Lack of effective treatment makes novel therapeutic discovery an urgent demand in PDAC research. By screening an epigenetic-related compound library, we identified THZ1, a covalent inhibitor of CDK7, as a promising candidate. Multiple long-established and patient-derived PDAC cell lines (PDC) were used to validate the efficacy of THZ1 in vitro. In addition, patient-derived xenograft (PDX) models and animal models of PDAC were utilized for examining THZ1 efficacy in vivo. Furthermore, RNA-Seq analyse was performed to reveal the molecular mechanism of THZ1 treatment. Finally, PDAC cell lines with primary or acquired resistance to THZ1 were investigated to explore the potential mechanism of THZ1 susceptibility. CDK7 inhibition was identified as a selective and potent therapeutic strategy for PDAC progression in multiple preclinical models. Mechanistic analyses revealed that CDK7 inhibition led to a pronounced downregulation of gene transcription, with a preferential repression of mitotic cell cycle and NF-κB signaling-related transcripts. MYC transcriptional was found to be involved in susceptibility of PDAC cells to CDK7 inhibition. In conclusion, Identification of CDK7-dependent transcriptional addiction in PDACs provides a potent therapeutic strategy that targets highly aggressive pancreatic cancer.Keywords
This publication has 34 references indexed in Scilit:
- Cotargeting of Epidermal Growth Factor Receptor and PI3K Overcomes PI3K–Akt Oncogenic Dependence in Pancreatic Ductal AdenocarcinomaClinical Cancer Research, 2014
- Targeting transcription regulation in cancer with a covalent CDK7 inhibitorNature, 2014
- The Epidemiology of Pancreatitis and Pancreatic CancerGastroenterology, 2013
- Revisiting Global Gene Expression AnalysisCell, 2012
- KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- STAT3 Plays a Critical Role in KRAS-Induced Pancreatic TumorigenesisCancer Research, 2011
- Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced SenescenceCancer Cell, 2011
- Pancreatic CancerNew England Journal of Medicine, 2010
- Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in miceCancer Cell, 2005
- Expression and functional significance of CDC25B in human pancreatic ductal adenocarcinomaOncogene, 2004